S. No. | Study report | Sample size | Total HPV positivity n (%) | HPV16 n (%) | HPV18 n (%) | HPV16/18 n (%) | Other HPV types n (%) | Country |
---|---|---|---|---|---|---|---|---|
1 | Di Lonardo et al., 1992 | 70 | 7 (10) | 7 (100) | 0 | 0 | 0 | Italy |
2 | Henning et al., 1999 | 41 | 19(46.3) | 19 (100) | 0 | 0 | 0 | Sweden |
3. | Yu et al., 1999 | 72 | 19(26.3) | 0 | 0 | 0 | 19 (HPV 33) | China |
4. | Yu et al., 2000 | 32 | 14(43.8) | 0 | 0 | 0 | 14(HPV33) | China |
5. | Liu et al., 2004 | 17 | 6(35) | 3(50) | 1(17) | 0 | 0 | China |
6. | Damin et al., 2004 | 101 | 25(24.7) | 14(56) | 10(40) | 1(4) | 0 | Brazil |
7. | Widschwendter et al., 2004 | 11 | 7(63.7) | 7(100) | 0 | 0 | 0 | Austria* |
8. | de Villiers et al., 2005 | 29 | 25(86.2) | 3(12) | 0 | 0 | 22(88) | USA* |
9. | Kroupis et al., 2006 | 107 | 17(15.9) | 14(82.3) | 0 | 0 | 3(17.6) | Greece |
10. | Kan et al., 2005 | 50 | 24(48) | 0 | 24(100) | 0 | 0 | Australia |
11. | Gumus et al., 2006 | 50 | 37(74) | 0 | 20(54) | 0 | 35(94.6) | Turkey |
12. | Khan et al., 2008 | 124 | 26(20.9) | 26(100) | 0 | 0 | 0 | Japan |
13. | de Leon et al., 2009 | 51 | 15(29.5) | 10(66.7) | 3(20) | 2(13.3) | 0 | Mexico |
14. | Mendizabal-Ruiz et al., 2009 | 67 | 3(4) | 1(33.3) | 1(33.3) | 0 | 1(33.3) | Mexico |
15. | Heng et al., 2009 | 26 biopsies | 8 (30.7) | 1 (3.8) | 7 (26.9) | 0 | 0 | Australia |
 |  | 9 cell lines | 2 (22) | 0 | 2 (22) | 0 | 0 |  |